EPHA2 and breast cancer: We report herein that TF and EphA2 co-localizes in MDA-MB-231 breast cancer cells with constitutive high TF expression and in TF transfected U251 glioblastoma cells, and that FVIIa sensitizes MDA-MB-231 cells to ephrin-A1-mediated cytoskeletal reorganization and cell rounding independently of PAR2-activation through a RhoA/ROCK pathway.